Suppr超能文献

炎症性肠病中的固有免疫:一种疾病假说。

Innate immunity in inflammatory bowel disease: a disease hypothesis.

作者信息

Marks D J B, Segal A W

机构信息

Centre for Molecular Medicine, University College London, UK.

出版信息

J Pathol. 2008 Jan;214(2):260-6. doi: 10.1002/path.2291.

Abstract

Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease.

摘要

克罗恩病源于胃肠道中高度密集的细菌群与下层组织之间的缺陷性相互作用。人们普遍认为它是由过度旺盛的炎症反应或“自身免疫”引起的。最近有证据表明,问题其实在于身体对细菌和其他肠内容物穿透肠黏膜屏障的反应方式存在缺陷。克罗恩病并非由过度炎症引起,其主要机制实际上是免疫缺陷。炎症介质产生不足导致中性粒细胞募集不足,从而致使细菌和其他碎屑清除不充分。在某些情况下,通过NOD2信号传导可补偿急性炎症的这种损害。如果未被清除,肠壁中的异物会被巨噬细胞摄取,引发肉芽肿反应以及克罗恩病特有的局部和全身后遗症。

相似文献

1
Innate immunity in inflammatory bowel disease: a disease hypothesis.
J Pathol. 2008 Jan;214(2):260-6. doi: 10.1002/path.2291.
3
Is Crohn's disease due to defective immunity?
Gut. 2007 Jan;56(1):2-5. doi: 10.1136/gut.2006.095588.
4
Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn's disease.
Swiss Med Wkly. 2010 Dec 27;140:w13135. doi: 10.4414/smw.2010.13135. eCollection 2010.
5
NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease.
Mucosal Immunol. 2011 Sep;4(5):484-95. doi: 10.1038/mi.2011.29. Epub 2011 Jul 13.
6
Defective innate immunity in inflammatory bowel disease: a Crohn's disease exclusivity?
Curr Opin Gastroenterol. 2011 Jul;27(4):328-34. doi: 10.1097/MOG.0b013e3283463b45.
7
Studies on patients establish Crohn's disease as a manifestation of impaired innate immunity.
J Intern Med. 2019 Oct;286(4):373-388. doi: 10.1111/joim.12945. Epub 2019 Jun 27.
8
NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
J Endotoxin Res. 2007;13(3):135-9. doi: 10.1177/0968051907080429.
9
New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options?
Swiss Med Wkly. 2009 Sep 19;139(37-38):527-34. doi: 10.4414/smw.2009.12520.
10
Crohn's disease: innate immunodeficiency?
World J Gastroenterol. 2006 Nov 14;12(42):6751-5. doi: 10.3748/wjg.v12.i42.6751.

引用本文的文献

1
Correlation between PDGF-BB and M1-type macrophage in inflammatory bowel disease: a case-control study.
BMC Gastroenterol. 2024 Nov 20;24(1):417. doi: 10.1186/s12876-024-03518-y.
5
Cdx2 regulates immune cell infiltration in the intestine.
Sci Rep. 2021 Aug 4;11(1):15841. doi: 10.1038/s41598-021-95412-w.
7
PIR-B Regulates CD4 IL17a T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory Responses.
Cell Mol Gastroenterol Hepatol. 2021;12(4):1479-1502. doi: 10.1016/j.jcmgh.2021.06.013. Epub 2021 Jul 6.
8
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses.
Brain Commun. 2020 Aug 13;2(2):fcaa124. doi: 10.1093/braincomms/fcaa124. eCollection 2020.
9
Anti-Inflammatory Effect of a Peptide Derived from the Synbiotics, Fermented with , on Inflammatory Bowel Disease.
Mediators Inflamm. 2020 Jul 4;2020:3572809. doi: 10.1155/2020/3572809. eCollection 2020.
10
Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases.
World J Clin Cases. 2020 Apr 26;8(8):1361-1384. doi: 10.12998/wjcc.v8.i8.1361.

本文引用的文献

2
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
Science. 2006 Dec 1;314(5804):1461-3. doi: 10.1126/science.1135245. Epub 2006 Oct 26.
4
Can unresolved infection precipitate autoimmune disease?
Curr Top Microbiol Immunol. 2006;305:105-25. doi: 10.1007/3-540-29714-6_6.
5
New genes in inflammatory bowel disease: lessons for complex diseases?
Lancet. 2006 Apr 15;367(9518):1271-84. doi: 10.1016/S0140-6736(06)68345-1.
6
Evolving knowledge and therapy of inflammatory bowel disease.
Nat Rev Drug Discov. 2006 Mar;5(3):197-209. doi: 10.1038/nrd1986.
7
Defective acute inflammation in Crohn's disease: a clinical investigation.
Lancet. 2006 Feb 25;367(9511):668-78. doi: 10.1016/S0140-6736(06)68265-2.
8
Serologic markers in inflammatory bowel disease.
Clin Chem. 2006 Feb;52(2):171-81. doi: 10.1373/clinchem.2005.058560. Epub 2005 Dec 8.
10
Sargramostim for active Crohn's disease.
N Engl J Med. 2005 May 26;352(21):2193-201. doi: 10.1056/NEJMoa041109.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验